Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence.

Lina H AlLehaibiMukhtar AlomarAbdulaziz AlmulhimSarah Al-MakkiNazar R AlrwailiShahad Al-BassamSemat AlsultanJenan Al SaeedMohammad AlsheefIvo Abraham Ahmed A Alamer

Published in: The Annals of pharmacotherapy (2022)

When compared with UFH, enoxaparin was associated with a significant reduction in thrombotic events or mortality among COVID-19 patients. The results need confirmation from randomized controlled trials.

Keyphrases

venous thromboembolism
sars cov
direct oral anticoagulants
randomized controlled trial
cardiovascular events
risk factors
coronary artery disease
study protocol
meta analyses